CML HealthCare Income Fund Reports 2009 Third Quarter Financial Results
Lonza successfully develops a manufacturing process for ArzerraTM (ofatumumab), a new biopharmaceutical from GSK and Genmab
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
CML HealthCare Income Fund Announces Release Date for Fiscal 2009 Third Quarter Financial Results
ORTHO CLINICAL DIAGNOSTICS LAUNCHES FETALSCREEN(TM) II FETAL MATERNAL HEMORRHAGE SCREENING TEST
Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems
University of Southern California receives $1 million NIH grant to study TXA127 for the prevention of radiation damage
Tarix Pharmaceuticals receives FDA approval for Phase 2 study to mitigate chemotherapy-induced thrombocytopenia
Clients in focus...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd All rights reserved. Terms and Conditions | Contact us
All rights reserved. Terms and Conditions | Contact us
